This Sounding Board announces a new FDA policy that the default requirement for FDA approvals will be one robust pivotal trial plus confirmatory evidence, rather than two trials.

Treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I under review.

CALGARY, AB, Jan. 23, 2026 /PRNewswire/ - NuVista Energy Ltd. (TSX: NVA) ("NuVista") and Ovintiv Inc. (NYSE: OVV) (TSX: OVV) ("Ovintiv") are pleased to announce that ...

Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump's approval ratings slightly dipped in most polls following a series of controversial events at the start of ...

Morgan Stanley has filed with U.S. regulators to launch a spot bitcoin ETF, signaling growing institutional confidence in regulated bitcoin investment products. Morgan Stanley has filed with U.S.

Decades ago, patients who were diagnosed with acute myeloid leukemia, a rare cancer of the bone marrow and blood, were told there was nothing doctors could do for them. In part due to pioneering ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

The American depository receipts of Novo Nordisk rose after the tablet formulation of the company's GLP-1 weight loss drug received approval from the Food and Drug Administration. Novo Nordisk's ADRs ...

Catalent’s sweeping workforce reductions within its Maryland gene therapy manufacturing operations were preceded by two FDA inspections in April that resulted in red flags from the agency, FDA filings ...

PayPal said it has applied for approval to form PayPal Bank, which would be able to extend loans to small businesses. The company has applications pending with the state of Utah and the Federal ...